Mark Murcko
Director at Relay Therapeutics, Inc. (RLAY)
Mark Murcko has filed 6 insider reports with the SEC since May 2022, as director at Relay Therapeutics, Inc. (RLAY). Mark Murcko made no open-market purchases or sales in the last 12 months. The latest filing, on June 10, 2026, reports grant or award at Relay Therapeutics, Inc. (RLAY).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- $749K
Companies where Mark Murcko is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 996,952 | $749K | $16.51 | Jun 10, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 9, 2026RLAYSEC Form 4 filed by Director Murcko MarkForm 4Grant or award
- Jun 6, 2025RLAYSEC Form 4 filed by Director Murcko MarkForm 4Grant or award
- Jun 3, 2024RLAYSEC Form 4 filed by Murcko MarkForm 4Grant or award
- May 31, 2023RLAYSEC Form 4 filed by Murcko MarkForm 4Grant or award
- Sep 8, 2022-$749KRLAYSEC Form 4: Murcko Mark sold $748,750 worth of shares (25,000 units at $29.95) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 996,952 unitsForm 4Open-market sale10b5-1 plan
- May 27, 2022RLAYSEC Form 4 filed by Murcko MarkForm 4Grant or award
Compare Mark Murcko with
- Mark Murcko vs Donald A Bergstrom1 shared
- Mark Murcko vs Thomas Catinazzo1 shared
- Mark Murcko vs Sanjiv Patel1 shared
- Mark Murcko vs Peter Rahmer1 shared
- Mark Murcko vs Claire Mazumdar1 shared
- Mark Murcko vs Alexis Borisy1 shared
Other insiders at the same companies
- Donald A BergstromRLAY
- Thomas CatinazzoRLAY
- Sanjiv PatelRLAY
- Peter RahmerRLAY
- SVF Pauling (Cayman) LtdRLAY
- Claire MazumdarRLAY
- Douglas S IngramRLAY
- Alexis BorisyRLAY
- Linda A HillRLAY
- Habib J DableRLAY
- Lonnel CoatsRLAY
- Brian AdamsRLAY
- Sekar KathiresanRLAY
- Jami RubinRLAY
Questions about Mark Murcko
- What is Mark Murcko's role at Relay Therapeutics, Inc.?
- Mark Murcko reports to the SEC as director at Relay Therapeutics, Inc. (RLAY), according to the latest filing on June 10, 2026.
- How many shares does Mark Murcko own?
- After the latest filing that states it, Mark Murcko directly owned 996,952 shares of Relay Therapeutics, Inc. (RLAY). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Mark Murcko bought or sold stock recently?
- The most recent open-market sale was on September 8, 2022: sold 25,000 shares of Relay Therapeutics, Inc. (RLAY) for $749K at an average of $29.95.
- How do I get alerts when Mark Murcko files?
- Follow Mark Murcko on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Mark Murcko (SEC CIK 0001816130). Totals count each trade once, skipping amendments whose original is on file, from May 27, 2022 on. View on SEC EDGAR